Several immunologic aberrations have been associated with the development of autoimmunity in humans and experimental models. The main such abnormalities are the following:
• Defective self-tolerance. Inadequate elimination or regulation of T or B cells, leading to an imbalance between lymphocyte activation and control, is the underlying cause of autoimmune diseases. The potential for autoimmunity exists in all individuals because some of the clones of developing lymphocytes may express receptors specific for self antigens, and not all of these clones are deleted during their maturation, so many self-reactive lymphocytes are present in healthy individuals. Also, many self antigens are readily accessible to lymphocytes. As discussed earlier, tolerance to self antigens is normally maintained by selection processes that prevent the maturation of some self antigen–specific lymphocytes and by mechanisms that inactivate or delete self-reactive lymphocytes that do mature. Experimental models and some results from analyses of human diseases, particularly mono genic disorders of immune regulation, have shown that any of the following mechanisms may contribute to the failure of self-tolerance:
• Defects in deletion (negative selection) of T or B cells or receptor editing in B cells during the maturation of these cells in the generative lymphoid organs
• Defective numbers or functions of regulatory T lymphocytes or resistance of effector cells to Treg-mediated control
• Defective apoptosis of mature self-reactive lymphocytes
• Defects in expression or function of inhibitory receptors
• Abnormal display of self antigens. Abnormalities may include structural changes in self antigens resulting from enzymatic modifications or from cellular stress or injury. If these changes lead to the display of antigenic epitopes that are not present normally, the immune system may not be tolerant to these “neoantigens,” thus allowing anti-self responses to develop. Examples include citrullination of various self peptides in rheumatoid arthritis and posttranslational modifications of islet proteins in type 1 diabetes.
• Inflammation or an initial innate immune response. As we have discussed in previous chapters, the innate immune response is a strong stimulus for the activation of lymphocytes and the generation of adaptive immune responses. Infections or cell injury may elicit local innate immune reactions with inflammation. These may contribute to the development of autoimmune disease, perhaps by activating APCs to express increased levels of costimulators, which overcome regulatory mechanisms and result in excessive T-cell activation. Cytokines made during innate immune responses are also capable of activating T and B lymphocytes. An example is the production of type I IFN associated with SLE and other autoimmune diseases.
Much recent attention has focused on the role of T cells in autoimmunity for two main reasons. First, helper T cells are the key regulators of both cell-mediated and humoral immune responses to proteins, and most self antigens implicated in auto immune diseases are proteins. Second, the risk for developing several autoimmune diseases is associated with the inheritance of certain MHC alleles (the HLA [human leukocyte antigen] complex in humans), and the function of MHC molecules is to present peptide antigens to T cells. Failure of self-tolerance in T lymphocytes may result in autoimmune diseases in which tissue damage is caused by cell-mediated immune reactions. Helper T-cell abnormalities may also lead to autoantibody production because helper T cells are necessary for the production of high affinity antibodies against protein antigens.
In the following section, we describe the general principles of the pathogenesis of autoimmune diseases, with an emphasis on susceptibility genes, infections, and other factors that con tribute to the development of autoimmunity. We will describe the pathogenesis and features of some illustrative autoimmune diseases in Chapter 19.